Matriptase is a transmembrane serine protease comprising multiple domains in the extracellular region, including a stem domain and a catalytic domain. Using soluble matriptase variants containing entire extracellular domains or only the catalytic domain, the activity of this protease was found to depend solely on the catalytic domain. The stem domain had no significant effect on the activity.
Matriptase, or membrane-type serine protease 1 (MT-SP1), is a type II transmembrane serine protease that comprises multiple domains in the extracellular region, including a catalytic domain at the C-terminus (Fig. 1A) . [1] [2] [3] Hydrolysis of the peptide bond after Arg 614 of a latent matriptase molecule is catalyzed by another molecule, and the enzyme is activated (transactivation). 2, 3) The activated enzyme has trypsin-like activity, and is known to cleave to activate single-chain urokinase-type plasminogen activator (sc-uPA) and prohepatocyte growth factor, producing their active forms. 2, 3) In addition, matriptase activity appears to be required for the activation of a membrane-bound serine protease, prostasin. 1) These characteristics, together with abundant expression in epithelial cells such as enterocytes, lead to the proposal that matriptase is the key upstream-regulator of epithelial-cell turnover, including proliferation, migration, and differentiation.
Type II transmembrane serine proteases generally have extracellular non-catalytic domains (hereafter called the stem domain) consisting of various structural motifs.
1) It has been reported that enteropeptidase activity is greatly dependent on the stem domain. 4) Indeed, a soluble variant of recombinant (or r-) bovine enteropeptidase containing the entire extracellular domains cleaves the substrate trypsinogen with a catalytic efficiency 520 times higher than that of another variant consisting only of the catalytic domain. 4) The purpose of the present study was to determine whether the stem domain of matriptase would affect its activity.
We produced a soluble variant of recombinant matriptase (r-matriptase) containing the entire extracellular domains (Tyr 81 -Val 855 ) using CHO-K1 cells.
5) The r-matriptase variant is activated in vitro by r-enteropeptidase (Novagen, Madison, WI). In the present study, we designated this form of r-matriptase HL-matriptase (Fig. 1A ). An expression plasmid for the production of another soluble r-matriptase variant (designated L-matriptase) consisting of the catalytic domain (and its N-terminal spacer region) (Asp 603 -Val 855 ) was prepared as follows: A DNA fragment was amplified by PCR using KOD plus Ô DNA polymerase (Toyobo, Osaka, Japan), synthetic oligonucleotides (5 0 -TGACTG-TGGGCTGCGATCCTTTAC-3 0 and 5 0 -GCTCTAGA-TACCCCAGTTTGCTCTTTGAT-3 0 ) as primers, and the plasmid for HL-matriptase (pSec-ek-MT-SP1) 5) as the template. The PCR product was ligated into a SmaIlinearized pT7blue2 vector (Novagen), and the resulting plasmid was designated pt7C-MAT. The pt7C-MAT plasmid was digested with KpnI and BamHI, and the restriction fragment was ligated into pSec-ek-MT-SP1, which had been digested with KpnI and BamHI. The plasmid (pSecL-matriptase) was transfected into CHO-K1 cells as described previously. 5) A CHO-K1 clone with the highest expression of L-matriptase was selected. L-matriptase was purified and activated by r-enteropeptidase as described previously 5) except that Amicon Ò Ultra-15 (10,000 MWCO, Millipore, Ireland) was used to concentrate the conditioned media. The active matriptase variants were titrated as follows: Some of them were incubated with 1 mM of N-Boc-L-Gln-LAla-L-Arg-MCA (or Boc-QAR-MCA) (Peptide Institute, Osaka, Japan) in 25 mM HEPES buffer (pH 7.5) containing 145 mM NaCl and 0.1% Triton X-100 (hereinafter, HEPES buffer) for 10 min at 37 C in a volume of 80 ml. The reaction was terminated by adding 350 ml of a stop solution (0.1 M monochloroacetic acid in 0.1 M sodium acetate buffer, pH 4.0), and the absorbance at 370 nm was measured. One unit of activity was defined as the amount of the enzyme that librates 0.5 nmol of 7-amino-4-methylcoumarin/min from Boc-QAR-MCA, and the enzyme concentration was estimated by SDS-PAGE, followed by silver staining with bovine trypsin y To whom correspondence should be addressed. Fax: +81-75-753-6265; E-mail: inouye@kais.kyoto-u.ac.jp Abbreviations: Boc, t-butyloxycarbonyl; CHO, Chinese hamster ovary; -MCA, -4-methyl-coumaryl-7-amide; PCR, polymerase chain reaction; pNA, p-nitroaniline; r-, recombinant; sc-uPA, single-chain urokinase-type plasminogen activator; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; tc-uPA, two-chain uPA (type III, Sigma, St. Louis, MO) as the standard. One enzyme unit was given by 1 pmol enzyme. The hydrolysis of other peptidyl-MCA substrates (Peptide Institute) was determined as described above. The Michaelis constant (K m ) and molecular activity (k cat ) for Boc-QAR-MCA hydrolysis were determined with initial substrate concentrations ranging from 0.1 to 4.0 mM. The matriptase-catalyzed hydrolysis of sc-uPA was conducted as follows: The reaction was initiated by adding 15 ml of the HEPES buffer containing 0.5 nM active matriptase variants to 15 ml of the buffer containing various concentrations (0.5-8.0 mM) of r-human sc-uPA (Technoclone, Vienna, Austria). After incubation for 50 min at 37 C, 10 ml of 4.0 mM spectrozyme UK (sp-UK, N-carbobenzoxy-L-Glu-Gly-L-Arg-p-nitroanilide, American Diagnostica, Stanford, CT) dissolved in HEPES buffer was added to the mixtures. After further incubation for 5 min at 37 C, the reaction was terminated by adding 350 ml of the stop solution, and the absorbance at 405 nm of the product, p-nitroaniline (pNA), was measured. The initial rate (v 0 ) of hydrolysis was determined using a molar absorption coefficient of 9.65 mM À1 cm À1 of pNA. The kinetic parameters were determined by fitting the v 0 vs. [S] 0 plot directly to the Michaelis-Menten equation by nonlinear least-squares regression using the Kaleidagraph program (Synergy Software, Reading, PA).
Both HL-matriptase and L-matriptase were purified to homogeneity (>95%) as judged by SDS-PAGE and silver staining (data not shown). Figure 1B shows a representative Western blot data of HL-matriptase and L-matriptase probed with rabbit anti-rat matriptase catalytic-domain antibody.
6) HL-matriptase produced signals at the positions corresponding to 95 kDa and 28 kDa before and after enteropeptidase treatment respectively. L-matriptase also produced a signal at 28 kDa under enteropeptidase treatment, while it gave signals at the 40-, 35-, and 30-kDa positions without treatment. Judging from their sizes, the 40-and 35-kDa bands can be produced from L-matriptase species that contain S-tag (Fig. 1A) but are cleaved by signal peptidases of CHO-K1 cells at differential sites. The 30-kDa species can be the one that is cleaved at the first enteropeptidase recognition site (Fig. 1A) by an unknown mechanism. The kinetic parameters (K m , k cat , and k cat =K m ) of HL-matriptase and L-matriptase after treatment with r-enteropeptidase were characterized using Boc-QAR-MCA as follows: K m ¼ 590 AE 15 and 582 AE 20 mM; k cat ¼ 13:1 AE 1:8 and 13:7 AE 3:5 s À1 ; and k cat =K m ¼ 22:2 AE 3:6 and 23:7 AE 6:4 mM À1 s À1 , respectively (n ¼ 3). The activities of the two enzyme variants in the hydrolysis of the respective peptidyl-MCA substrates containing an Arg residue at the P1 site were similar (Table 1) . 3 and 4) . The matriptase variants, precipitated with immobilized S-protein (Novagen), were eluted by boiling (lanes 1 and 3) or by enteropeptidase treatment (lanes 2 and 4). Samples were separated by SDS-PAGE (12% gel) under reducing conditions, and the Western blot was probed with a rabbit anti-rat matriptase catalytic domain antibody. The molecular masses of the standard proteins are indicated on the left in kDa.
We also examined the conversion of sc-uPA into twochain uPA (tc-uPA) catalyzed by active matriptase variants. Preliminary experiments indicated that the hydrolysis of sp-UK, a specific substrate for tc-uPA, by sc-uPA and the active matriptase variants was negligible. Figure 2 shows the rate of pNA formation after incubation of sc-uPA at the concentrations indicated with the active matriptase variants. These data, combined with previously reported data 7) that 1 nM tc-uPA hydrolyzes a sp-UK-like substrate, L-Pyroglu-Gly-LArg-p-nitroanilide, at a rate of 6 nM/s, give the kinetic parameters of active HL-matriptase and active Lmatriptase in the hydrolysis of sc-uPA into tc-uPA: K m ¼ 3:52 AE 0:18 and 5:99 AE 0:58 mM, k cat ¼ 0:71 AE 0:08 and 0:57 AE 0:09 s À1 , and k cat =K m ¼ 202 AE 32 and 95 AE 22 mM À1 s À1 (Fig. 2) . On the basis of the kinetic data, we conclude that matriptase activity is dependent only on the catalytic domain, that the stem domain has no significant effect on the activity, and that the role of the stem domain of matriptase is different from that of enteropeptidase. It has been reported that some human matriptase variants bearing mutations within the stem domain were not activated when expressed in BT549 breast cancer cells.
2) Hence, there is a possibility that the stem domain plays an important role in the interaction between latent matriptase molecules that is indispensable for activation. Fig. 2 . Conversion of sc-uPA into tc-uPA by HL-Matriptase and L-Matriptase. Assays were performed as described in the text. The vertical axis shows the initial reaction rate (v 0 ) of pNA formation from sp-UK, which is catalyzed by tc-uPA generated by incubating sc-uPA with matriptase variants.
